GSK’s Arexvy Is First RSV Vaccine Approved By FDA, But A Second Is Poised To Follow

 
• By Jessica Merrill
  
finish line
GSK got its RSV vaccine across the FDA finish line first • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip